Version 1
: Received: 23 February 2023 / Approved: 24 February 2023 / Online: 24 February 2023 (08:50:13 CET)
How to cite:
van Mechelen, M.; Lemmens, D.; Vanroy, C.; Truijen, S.; Saeys, W. Home-Based Moderate Intensity Cycling in Community Dwelling Individuals With Stroke: Protocol of a Randomised Controlled Study. Preprints2023, 2023020421. https://doi.org/10.20944/preprints202302.0421.v1
van Mechelen, M.; Lemmens, D.; Vanroy, C.; Truijen, S.; Saeys, W. Home-Based Moderate Intensity Cycling in Community Dwelling Individuals With Stroke: Protocol of a Randomised Controlled Study. Preprints 2023, 2023020421. https://doi.org/10.20944/preprints202302.0421.v1
van Mechelen, M.; Lemmens, D.; Vanroy, C.; Truijen, S.; Saeys, W. Home-Based Moderate Intensity Cycling in Community Dwelling Individuals With Stroke: Protocol of a Randomised Controlled Study. Preprints2023, 2023020421. https://doi.org/10.20944/preprints202302.0421.v1
APA Style
van Mechelen, M., Lemmens, D., Vanroy, C., Truijen, S., & Saeys, W. (2023). Home-Based Moderate Intensity Cycling in Community Dwelling Individuals With Stroke: Protocol of a Randomised Controlled Study. Preprints. https://doi.org/10.20944/preprints202302.0421.v1
Chicago/Turabian Style
van Mechelen, M., Steven Truijen and Wim Saeys. 2023 "Home-Based Moderate Intensity Cycling in Community Dwelling Individuals With Stroke: Protocol of a Randomised Controlled Study" Preprints. https://doi.org/10.20944/preprints202302.0421.v1
Abstract
Objective: To investigate the feasibility and preliminary effects of a 12-week home-based moderate intensity cycling programme in stroke survivors. Design: Single-blinded, parallel group, Randomised Controlled Trial Setting: Home-based Participants: Participants will be survivors of first-ever stroke and randomly assigned to an Active Cycling Group (ACG) or control group. Intervention: The ACG performed a 12-week home-based cycling programme, three sessions per week. Work intervals were executed at 75% of the maximal heart rate (HRmax), recovery intervals at 50% of HRmax. Work interval duration increased from three ten-minute intervals to 30 minutes continuous cycling. The control group completed a 12-week neurocognitive exercise programme. Main outcome measurements: Primary outcome measures are compliance with training, adherence to protocol and safety as measured by adverse events. Secondary outcome measurements included a: simplified modified Rankin Scale questionnaire (stroke severity), Six-Minute Walking Test (walking ability), Ten-meter Walk Test (walking ability), Rivermead Mobility Index (walking ability), graded submaximal cycling test (exercise capacity), Physical Activity for Individuals with Physical Disability questionnaire (physical activity), EQ-5D-5L (quality of life), Stroke Specific Quality of Life questionnaire (quality of life), Montreal Cognitive Assessment (cognition), General Self-Efficacy Scale (self-efficacy), and Exercise Self-Regulation Questionnaire (self-regulation).
Medicine and Pharmacology, Neuroscience and Neurology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
